by Truveta staff | Sep 12, 2023 | News
Medical Components, Inc. and Truveta are partnering to advance the use of real-world data to improve clinical care for patients battling cancer and kidney disease who require advanced vascular access for treatment. Truveta delivers the most complete, timely, and clean...
by Truveta staff | Aug 9, 2023 | Data, News
Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication adherence, and adverse events. Medication dispense data helps researchers understand patients’ actual use of medications. With...
by Truveta staff | May 17, 2023 | News
We are excited to announce the expansion of the Truveta community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously announced pioneers Pfizer, Boston Scientific Corporation, and Alpine Immune Sciences. We...
by Truveta Research | May 11, 2023 | News, Research
Today Truveta announced a new research letter published in JAMA Network Open using de-identified patient data from Truveta Studio. Published in collaboration with Anupam B. Jena, MD, PhD and Christopher M Worsham, MD, MPH from Harvard University, the new research...
by Truveta staff | May 4, 2023 | News
This post is authored by Tricia Rodriguez, senior applied scientist, Truveta Research. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is gearing up for a fantastic event, slated for May 7-10, 2023, in Boston. As an applied scientist with...
by Terry Myerson, CEO | Apr 12, 2023 | News, Technology
UPDATE: Truveta has won the 2024 South by Southwest (SXSW) Innovation Award in Artificial Intelligence for its AI-enabled health research and the Truveta Language Model (TLM). Healthcare data traditionally has been siloed, inaccessible, and too messy to be useful for...
